These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23649890

  • 1. Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.
    Kaspers S, Ranke MB, Han D, Loftus J, Wollmann H, Lindberg A, Roelants M, Kleintjens J.
    Appl Health Econ Health Policy; 2013 Jun; 11(3):237-49. PubMed ID: 23649890
    [Abstract] [Full Text] [Related]

  • 2. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Jun; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 3. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
    Ranke MB, Lindberg A, Brosz M, Kaspers S, Loftus J, Wollmann H, Kołtowska-Haggstrom M, Roelants M.
    Horm Res Paediatr; 2012 Jun; 78(1):8-17. PubMed ID: 22832697
    [Abstract] [Full Text] [Related]

  • 4. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT.
    Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651
    [Abstract] [Full Text] [Related]

  • 7. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 19; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 8. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
    Ranke MB, Lindberg A, KIGS International Board.
    J Clin Endocrinol Metab; 2010 Mar 19; 95(3):1229-37. PubMed ID: 20097713
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M, Iughetti L, Loche S, Maghnie M, Vottero A, GeNeSIS National Board on behalf of the GeNeSIS Italian Investigators.
    J Endocrinol Invest; 2016 Jun 19; 39(6):667-77. PubMed ID: 27223400
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan 19; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 11. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G, Baur F, Schweizer R, Ranke MB.
    J Clin Endocrinol Metab; 2006 Feb 19; 91(2):659-64. PubMed ID: 16291706
    [Abstract] [Full Text] [Related]

  • 12. Height gain in Ullrich-Turner syndrome after early and late growth hormone treatment start: results from a large retrospective German study and potential basis for an individualized treatment approach.
    Bettendorf M, Inta IM, Doerr HG, Hauffa BP, Mehls O, Ranke MB.
    Horm Res Paediatr; 2013 Feb 19; 80(5):356-62. PubMed ID: 24217296
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data.
    Bonfig W, Lindberg A, Carlsson M, Cutfield W, Dunger D, Camacho-Hübner C, Holl RW.
    J Pediatr; 2018 Jul 19; 198():260-264. PubMed ID: 29656861
    [Abstract] [Full Text] [Related]

  • 14. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, KIGS International Board. Kabi International Growth Study.
    J Clin Endocrinol Metab; 2000 Nov 19; 85(11):4212-8. PubMed ID: 11095456
    [Abstract] [Full Text] [Related]

  • 15. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O, Snajderova M, Blair J, Pournara E, Pedersen BT, Petit IO.
    Eur J Endocrinol; 2017 Aug 19; 177(2):145-155. PubMed ID: 28522645
    [Abstract] [Full Text] [Related]

  • 16. A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.
    Clayton P, Chatelain P, Tatò L, Yoo HW, Ambler GR, Belgorosky A, Quinteiro S, Deal C, Stevens A, Raelson J, Croteau P, Destenaves B, Olivier C.
    Eur J Endocrinol; 2013 Sep 19; 169(3):277-89. PubMed ID: 23761422
    [Abstract] [Full Text] [Related]

  • 17. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F, Lindberg A, Wilton P.
    Horm Res Paediatr; 2011 Sep 19; 76 Suppl 1():42-6. PubMed ID: 21778748
    [Abstract] [Full Text] [Related]

  • 18. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
    Reinehr T, Bechtold-Dalla Pozza S, Bettendorf M, Doerr HG, Gohlke B, Hauffa BP, Kaspers S, Land C, Mehls O, Schwab KO, Stahnke N, Ranke MB, German KIGS Study Board.
    Exp Clin Endocrinol Diabetes; 2011 Oct 19; 119(9):544-8. PubMed ID: 22006181
    [Abstract] [Full Text] [Related]

  • 19. Validation of a mathematical model predicting the response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency.
    Vosahlo J, Zidek T, Lebl J, Riedl S, Frisch H.
    Horm Res; 2004 Oct 19; 61(3):143-7. PubMed ID: 14676463
    [Abstract] [Full Text] [Related]

  • 20. International Comparison of Adult Height in Children with Growth Hormone Deficiency and Limitations of Growth Hormone Treatment in Japan.
    Tanaka T.
    Pediatr Endocrinol Rev; 2017 Mar 19; 14 Suppl 1(Suppl 1):216-221. PubMed ID: 28516749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.